Detalhe da pesquisa
1.
Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma.
Molecules
; 26(1)2020 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33374953
2.
Positive margin rates for colorectal cancer vary significantly by hospital in Michigan: Can we achieve a 0 % positive margin rate?
Surg Open Sci
; 16: 37-43, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766798
3.
225Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors.
J Nucl Med
; 64(4): 549-554, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396453
4.
Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET.
J Nucl Med
; 64(7): 1017-1023, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997331
5.
Comparison of arylboron-based nucleophiles in Ni-catalyzed Suzuki-Miyaura cross-coupling with aryl mesylates and sulfamates.
J Org Chem
; 77(14): 5956-64, 2012 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22712768
6.
Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand.
Chem Sci
; 12(10): 3733-3742, 2021 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34163647
7.
ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.
Theranostics
; 10(1): 151-165, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31903112
8.
In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency.
Cancer Biother Radiopharm
; 34(8): 498-503, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31424293
9.
Air-stable nickel precatalysts for fast and quantitative cross-coupling of aryl sulfamates with aryl neopentylglycolboronates at room temperature.
Org Lett
; 16(24): 6326-9, 2014 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25467653